IREN Announces Monthly Investor Update for February 2024
SYDNEY, Australia, March 06, 2024 (GLOBE NEWSWIRE) — IREN (Iris Energy Limited) (NASDAQ: IREN) (together with its subsidiaries, “IREN” or […]
Canoo Inc. Announces 1-for-23 Reverse Stock Split Effective March 8, 2024
Justin, TX, March 06, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (NASDAQ: GOEV), (“Canoo” or the “Company”), an advanced high-tech mobility company, […]
European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
Fiscal Year 2023 versus 2022 Net new centers increased 10.6% to 1,044 total centers in 45 states System-wide sales of […]
Smart Share Global Limited Launches New Power Bank Sustainability Campaign
SHANGHAI, China, March 06, 2024 (GLOBE NEWSWIRE) — Smart Share Global Limited (“Energy Monster” or the “Company”), a consumer tech […]
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a […]
JD.com Announces Fourth Quarter and Full Year 2023 Results, Annual Dividend and Share Repurchase Program
BEIJING, March 06, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), […]
Allot Wins Prestigious 2024 Frost & Sullivan Customer Value Leadership Award for CSP Security
Hod Hasharon, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of […]
Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic Function
Three Clinical Data Sets from the Dose Escalation Phase of COVALENT-111 to be Presented at the 17thAnnual ATTD Conference Highlighting […]
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused […]
Tims China to Present at Upcoming Conferences
SHANGHAI, China, and NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) — TH International Limited (NASDAQ THCH), the exclusive operator of […]
